Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-12 · accession 0001437749-22-022432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-14 | 2022-09-12+ | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $1.61 | +3,618 | 76.5K | +5% | +$5,813 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-12 | P | A | 968 | $1.57 | 73,850 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |
| 2 | Common | Common Stock | 2022-09-14 | P | A | 2,650 | $1.62 | 76,500 | D | — | — | (F1) Holdings do not include options to purchase 18,750 shares. |